Finance Digest.

Oil Whipsaws, Futures Sink as Trump's Hormuz Deadline Looms Over Jittery Markets

The S&P 500 rose 0.44% to 6,611.83, the Nasdaq Composite added 0.54% to 21,996.34, and the Dow gained 0.36% to 46,669.88 on Monday — but the calm may be short-lived. Stock index futures are sinking Tuesday as Trump's ...

Markets Overview

The S&P 500 rose 0.44% to 6,611.83, the Nasdaq Composite added 0.54% to 21,996.34, and the Dow gained 0.36% to 46,669.88 on Monday — but the calm may be short-lived. Stock index futures are sinking Tuesday as Trump's deadline for Iran to reopen the Strait of Hormuz approaches, with investors bracing for potential military escalation. The S&P 500 has dropped in five of the last six weeks and sits more than 5% below its recent high, while the Nasdaq recently dipped into correction territory, off more than 10% from its peak.

Prediction markets are flashing recession warnings as the Iran conflict pushes oil to multiyear highs, driving a rotation out of equities and into Treasuries. A strong March jobs report landed Friday to little fanfare — drowned out by $110 oil and Strait of Hormuz closure fears. As one strategist bluntly put it: the market, the Fed, and the economy are all ignoring war risks, and that complacency could be costly.

Earnings Reports

Delta Air Lines (DAL) kicks off airline earnings season with what analysts see as a jet fuel cost advantage, a notable edge as crude prices whipsaw. The read-through for the rest of the sector will depend heavily on how carriers hedged their fuel exposure heading into the Iran crisis.

Nike (NKE) shares plunged again after fiscal Q3 results showed the turnaround remains elusive, with the company continuing to struggle across key metrics in a pattern that has persisted for multiple quarters. Eli Lilly (LLY) is generating buzz after launching a $149/month weight-loss pill shipping immediately, with analysts projecting $101 billion in peak revenue — a figure that, if realized, would reshape the pharma landscape.

Fed & Economic Data

The Fed held rates steady at its March 18 meeting and shows no appetite to cut anytime soon, with surging oil prices and sticky inflation keeping the committee firmly on hold. One strategist goes further, arguing the Fed will eventually have to raise rates regardless of official denials, as energy-driven inflation pressures build.

Stagflation fears are creeping back into the conversation. Fed Chair Powell has acknowledged the tension between slowing growth signals and persistent price pressures, but the central bank appears content to wait. With oil above $110 and consumer spending under real pressure, the worst-case scenario — rising prices alongside stalling growth — is no longer a fringe view.

Hot Sectors

Energy is king. Oil-heavy names with Permian, offshore, and international crude exposure are dominating YTD performance charts, absolutely crushing natural gas-focused peers. Kosmos Energy (KOS) hit a 52-week high Monday, closing at $3.10 (+6.4%), while Goldman Sachs raised its Valero Energy (VLO) price target from $203 to $237. Goldman analysts are also addressing the critical question of whether the world is running short of oil, examining product supplies, price responses, and field-level anecdotes.

Tech is the contrarian play. Goldman Sachs is calling beaten-down U.S. tech stocks "a generational buying opportunity," arguing the selloff has created the best entry point in decades. Pipeline stocks are drawing income investors with high yields and relative insulation from the volatility. Costco (COST) is emerging as a surprise winner of rising gas prices, with its discount fuel, bulk essentials, and sticky membership model acting as a consumer magnet during the squeeze.

Stock News

Bill Ackman's Pershing Square has proposed a $64 billion merger involving Universal Music Group, calling his stake's performance "languishing" and seeking to address what he views as chronic underperformance. Separately, Ackman and Fundstrat's Tom Lee are both making the case that now is the time to buy equities despite the fear.

Neurocrine Biosciences is reportedly nearing an acquisition of Soleno Therapeutics to accelerate its push into obesity drugs, sending Soleno shares soaring in premarket. Boot Barn (BOOT) surged on an analyst upgrade, while Sezzle (SEZL) sizzled after a new buy-rated initiation. Sandisk (SNDK) rallied in sympathy with a bullish analyst note on a storage-industry peer. On the downside, IonQ (IONQ) collapsed 24.9% in March alone, extending a brutal Q1 for quantum computing names, and Dutch Bros (BROS) is down 24% over three months as growth-stock multiple compression continues.

Market Analysis

The dominant theme is unmistakable: geopolitics is the market now. Everything — sector rotation, rate expectations, earnings narratives — is running through the lens of the Iran conflict and oil supply disruption. Asia's fuel shortage is already creating a domino effect, with the Philippines declaring a national energy emergency and Indonesia facing a $22.5 billion problem, given that 84% of crude and 83% of LNG transiting Hormuz is Asia-bound.

What to watch this week: Trump's Tuesday deadline for Iran to reopen the Strait of Hormuz is the single most consequential catalyst. An escalation (strikes on Iranian power plants have been explicitly threatened) could send oil sharply higher and futures into a tailspin. A diplomatic resolution could trigger a violent reversal in energy names and a relief rally in growth. Delta's earnings will set the tone for how corporate America is absorbing the energy shock. Jamie Dimon's warning that Europe is on a "slow decline" — and that this is now a direct risk for U.S. investors with international exposure — deserves attention as Q1 earnings season broadens. Buckle up: this is not a week for autopilot.

Sources

Motley Fool · 2026-04-07
Why Ethereum Was Creeping Higher on Monday
Motley Fool · 2026-04-07
Is Valero Energy One of the Best Oil Stocks to Buy Right Now?
Motley Fool · 2026-04-07
Where Will Bittensor (TAO) Be in 3 Years?
Motley Fool · 2026-04-07
One Wall Street Analyst Sees Tesla Crashing 60%. Are They Right?
Motley Fool · 2026-04-07
Should This Trillion-Dollar "Magnificent Seven" Company Spend Billions to Buy Peloton in 2026?
Motley Fool · 2026-04-07
JPMorgan's Dimon Warns Europe Is on a Slow Decline -- and That Is Now a Direct Risk for U.S. Investors With International Exposure
Motley Fool · 2026-04-07
YieldMax AI Option Income Strategy ETF's Huge Yield Is Riskier Than You May Think
Motley Fool · 2026-04-07
With the Market Sliding, These Warren Buffett Stocks Are Worth Every Dollar of $1,000
Motley Fool · 2026-04-07
Best S&P 500 Stock to Buy Right Now After the Shares' Big Move
Motley Fool · 2026-04-07
Nike Shares Plummet Again. Will the Stock Ever Rebound?
Motley Fool · 2026-04-07
A Major Social Security Change May Be Closer Than You Think. Here's What It Could Mean for Your Benefits
Motley Fool · 2026-04-07
The Stock Market Just Flashed a Buy Signal. History Says the S&P 500 Will Do This Next.
Motley Fool · 2026-04-07
Costco: The Surprising Winner of Rising Gas Prices
Motley Fool · 2026-04-07
Nvidia, Apple, Alphabet, Amazon, and Microsoft Are Sending Shockwaves Through Wall Street With This $16 Billion Warning
Motley Fool · 2026-04-07
Is the Stock Market About to Fall Sharply? Prediction Markets Flash a Warning, but Wall Street Sees Buying Opportunities.
Motley Fool · 2026-04-07
Should You Really Buy Stocks Now? Fundstrat's Tom Lee and Billionaire Bill Ackman Offer an Answer That's Crystal Clear.
Marketwatch · 2026-04-07
Health insurers secured a better Medicare Advantage rate for 2027, and their stocks are soaring
Motley Fool · 2026-04-07
This Is the Average Social Security Benefit for Age 65
Motley Fool · 2026-04-07
Is This Biotech Stock Your Best Shot at Building a Millionaire-Making Position?
Motley Fool · 2026-04-07
Hold These 3 High-Yield Pipeline Stocks Forever and Let the Income Roll In
Motley Fool · 2026-04-07
3 Steps Every Retiree Should Take in April Before Tax Deadline
Marketwatch · 2026-04-07
‘Fire Country’ star Diane Farr lists her longtime artist’s retreat in Los Angeles for $2.8 million
Motley Fool · 2026-04-07
Are Stagflation Fears Creeping Back Into the Picture? Here's What the Data and Fed Chair Jerome Powell Have to Say.
Motley Fool · 2026-04-07
You'll Never Guess Which Healthcare Stock Delivered the Best First-Quarter Performance in the S&P 500.
Marketwatch · 2026-04-07
Bill Ackman says his stake in Universal Music has languished — and now he’s come up with a $64 billion offer
Motley Fool · 2026-04-07
Why NuScale Power Stock Sank 15.6% in March
Motley Fool · 2026-04-07
If You Buy OLLI Right Now and Hold Forever, Here's What Could Happen
Motley Fool · 2026-04-07
SoFi Stock Is Down 40%. Is This the Buying Opportunity of 2026?
Marketwatch · 2026-04-07
‘I paid the $10 entry fee’: A friend picked my March Madness bracket. Ethically, do I owe her half of my $150 winnings?
Motley Fool · 2026-04-07
The April 15 IRA Deadline Is Almost Here -- Here's What You Still Have Time to Do
Motley Fool · 2026-04-07
Market Crash: The Financial Stocks I'd Buy Without Hesitation
Motley Fool · 2026-04-07
Does Working Longer Always Increase Your Monthly Social Security Benefit?
Marketwatch · 2026-04-07
My wife and I want to move to Malaysia. Will we receive Social Security benefits there?
Motley Fool · 2026-04-07
Why Chevron Stock Surged Nearly 11% in March
Motley Fool · 2026-04-07
Dutch Bros Stock Is Down 24% Over the Past Three Months. Should Investors Buy the Dip?
Motley Fool · 2026-04-07
Microsoft Stock Is Down 30% From Its Peak. History Says This Is What Happens Next.
Motley Fool · 2026-04-07
This Big Bank Stock Trades at a Discount to Book Value -- Is It a Buy?
Motley Fool · 2026-04-07
Is Best Buy Stock Overvalued Right Now?
Motley Fool · 2026-04-07
Boeing's Biggest Strategic Challenge Explained in 1 Chart
Seeking Alpha · 2026-04-07
Delta leads off airline earnings season with a jet fuel advantage
Seeking Alpha · 2026-04-07
Xponential Fitness rallies after unveiling a plan to review strategic alternatives
Motley Fool · 2026-04-07
Why April 10 Could Be a Big Day for the Stock Market
Motley Fool · 2026-04-07
Should You Buy AbbVie Stock Before April 29?
Seeking Alpha · 2026-04-07
Organogenesis rises as PuraPlyAM succeeds in diabetic foot ulcers
Marketwatch · 2026-04-07
My second husband will leave me $540,000 if I bequeath him my $130,000 net worth. What will happen to my two sons?
Marketwatch · 2026-04-07
A generational buying opportunity has opened up for U.S. tech stocks, says Goldman Sachs
Seeking Alpha · 2026-04-07
Bed Bath & Beyond uses M&A to enter a new growth phase
Marketwatch · 2026-04-07
The market, the Fed and the economy are ignoring war risks, says this strategist
Seeking Alpha · 2026-04-07
MetLife sees Q1 variable investment income of at least $475M
Seeking Alpha · 2026-04-07
BYD Company faces reputational risk in Brazil
Seeking Alpha · 2026-04-07
Stock index futures sink as Trump's deadline to reopen Hormuz approaches